Maki Niijima

Title: Maki Niijima: Innovator in Thyroid Hormone Research

Introduction

Maki Niijima is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that target thyroid hormone receptors. Her innovative work has the potential to impact the treatment of various diseases related to thyroid hormone action.

Latest Patents

Maki Niijima holds a patent for a heterocyclic derivative that acts as a thyroid hormone β receptor agonist. This compound is effective for the prophylaxis or treatment of diseases associated with thyroid hormone action. The patent describes a compound represented by a specific formula, along with its pharmacologically acceptable salts and a medicament containing the compound as an active ingredient. She has 1 patent to her name.

Career Highlights

Niijima is currently employed at Mitsubishi Tanabe Pharma Corporation, where she continues her research and development efforts. Her work at the company has positioned her as a key player in the pharmaceutical industry, focusing on innovative solutions for thyroid-related health issues.

Collaborations

Maki Niijima collaborates with notable colleagues, including Shinji Kawata and Koji Matsumoto. These partnerships enhance her research capabilities and contribute to the advancement of their shared goals in pharmaceutical innovation.

Conclusion

Maki Niijima's contributions to thyroid hormone research exemplify her dedication to advancing medical science. Her innovative patent and collaborative efforts highlight her role as a significant inventor in the pharmaceutical field.